Last reviewed · How we verify
AD313
At a glance
| Generic name | AD313 |
|---|---|
| Also known as | atomoxetine dronabinol |
| Sponsor | Apnimed |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED) (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |